Validation of BP devices QardioArm® in the general population and Omron M6 Comfort® in type II diabetic patients according to the European Society of Hypertension International Protocol (ESH-IP)

Validation of BP devices QardioArm® in the general population and Omron M6 Comfort® in type II diabetic patients according to the European Society of Hypertension International Protocol (ESH-IP)

Mirna N Chahine,1,2 Jirar Topouchian,3,4 Parounak Zelveian,3 Zoya Hakobyan,3 Arevik Melkonyan,3 Alaa Azaki,1 Reem Diab,1 Aya Harb,1 Roland Asmar1,2 1Faculty of Medical Sciences, Lebanese University, Hadath, Lebanon; 2Foundation-Medical Research Institutes (F-MRI), Beirut, Lebanon; 3Preventive Cardio...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Chahine MN, Topouchian J, Zelveian P, Hakobyan Z, Melkonyan A, Azaki A, Diab R, Harb A, Asmar R
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2017
Materias:
QardioArm®
Omron M6 Comfort®
validation
Blood pressure measurement
Type II diabetes
International Protocol.
Medical technology
R855-855.5
Acceso en línea:https://doaj.org/article/6ecb4a3fe0de4dc98ffd54f7539d48b1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:6ecb4a3fe0de4dc98ffd54f7539d48b1
record_format dspace
spelling oai:doaj.org-article:6ecb4a3fe0de4dc98ffd54f7539d48b12021-12-02T04:34:28ZValidation of BP devices QardioArm® in the general population and Omron M6 Comfort® in type II diabetic patients according to the European Society of Hypertension International Protocol (ESH-IP)1179-1470https://doaj.org/article/6ecb4a3fe0de4dc98ffd54f7539d48b12017-12-01T00:00:00Zhttps://www.dovepress.com/validation-of-bp-devices-qardioarm-in-the-general-population-and-omron-peer-reviewed-article-MDERhttps://doaj.org/toc/1179-1470Mirna N Chahine,1,2 Jirar Topouchian,3,4 Parounak Zelveian,3 Zoya Hakobyan,3 Arevik Melkonyan,3 Alaa Azaki,1 Reem Diab,1 Aya Harb,1 Roland Asmar1,2 1Faculty of Medical Sciences, Lebanese University, Hadath, Lebanon; 2Foundation-Medical Research Institutes (F-MRI), Beirut, Lebanon; 3Preventive Cardiology Center, Yerevan, Armenia; 4Diagnostic Center, Hotel-Dieu Hospital, Paris, France Background: Following the European Society of Hypertension International Protocol (ESH-IP) Revision 2010, QardioArm® and Omron M6 Comfort IT® oscillometric devices were evaluated in the general population and in patients with type II diabetes, respectively, for self-blood pressure (BP) measurement. Methods: Both devices, QardioArm® and Omron M6 Comfort®, measure BP at the brachial level. The ESH-IP Revision 2010 includes a total number of 33 subjects. For each measure, the difference between observer and device BP values was calculated. In all, 99 pairs of BP differences are classified into three categories (≤5, ≤10, and ≤15 mmHg). The protocol procedures were followed precisely. Results: QardioArm® and Omron M6 Comfort® fulfilled the requirements of the ESH-IP and passed the validation process successfully. For QardioArm®, a total of 69 out of 99 comparisons for systolic blood pressure (SBP) showed an absolute difference within 5 mmHg and 82 out of 99 for diastolic blood pressure (DBP). As for Omron M6 Comfort®, a total of 83 out of 99 comparisons for SBP showed an absolute difference within 5 mmHg and 77 out of 99 for DBP. The mean differences between the device and mercury readings were 0.7±5.9 mmHg for SBP and 0.3±4.1 mmHg for DBP for QardioArm® and −1.4±4.7 mmHg for SBP and −2.1±4.3 mmHg for DBP for Omron M6 Comfort®. With regard to part 2 of ESH-IP 2010, 27 out of 33 subjects had a minimum of two out of three measurements within 5 mmHg difference for SBP and 31 out of 33 subjects for DBP for the QardioArm®, and 29 out of 33 patients had a minimum of two out of three measurements within 5 mmHg difference for SBP and 26 out of 33 patients for DBP for Omron M6 Comfort®.Conclusion: QardioArm® and Omron M6 Comfort® readings differing from the mercury standard by <5, 10, and 15 mmHg fulfill the ESH-IP Revision 2010 requirements. Consequently, these two devices are suitable for use in the general population and non-insulin-dependent type II diabetic patients, respectively. Keywords: QardioArm®, Omron M6 Comfort®, validation, blood pressure measurement, type II diabetes, International ProtocolChahine MNTopouchian JZelveian PHakobyan ZMelkonyan AAzaki ADiab RHarb AAsmar RDove Medical PressarticleQardioArm®Omron M6 Comfort®validationBlood pressure measurementType II diabetesInternational Protocol.Medical technologyR855-855.5ENMedical Devices: Evidence and Research, Vol Volume 11, Pp 11-20 (2017)
institution DOAJ
collection DOAJ
language EN
topic QardioArm®
Omron M6 Comfort®
validation
Blood pressure measurement
Type II diabetes
International Protocol.
Medical technology
R855-855.5
spellingShingle QardioArm®
Omron M6 Comfort®
validation
Blood pressure measurement
Type II diabetes
International Protocol.
Medical technology
R855-855.5
Chahine MN
Topouchian J
Zelveian P
Hakobyan Z
Melkonyan A
Azaki A
Diab R
Harb A
Asmar R
Validation of BP devices QardioArm® in the general population and Omron M6 Comfort® in type II diabetic patients according to the European Society of Hypertension International Protocol (ESH-IP)
description Mirna N Chahine,1,2 Jirar Topouchian,3,4 Parounak Zelveian,3 Zoya Hakobyan,3 Arevik Melkonyan,3 Alaa Azaki,1 Reem Diab,1 Aya Harb,1 Roland Asmar1,2 1Faculty of Medical Sciences, Lebanese University, Hadath, Lebanon; 2Foundation-Medical Research Institutes (F-MRI), Beirut, Lebanon; 3Preventive Cardiology Center, Yerevan, Armenia; 4Diagnostic Center, Hotel-Dieu Hospital, Paris, France Background: Following the European Society of Hypertension International Protocol (ESH-IP) Revision 2010, QardioArm® and Omron M6 Comfort IT® oscillometric devices were evaluated in the general population and in patients with type II diabetes, respectively, for self-blood pressure (BP) measurement. Methods: Both devices, QardioArm® and Omron M6 Comfort®, measure BP at the brachial level. The ESH-IP Revision 2010 includes a total number of 33 subjects. For each measure, the difference between observer and device BP values was calculated. In all, 99 pairs of BP differences are classified into three categories (≤5, ≤10, and ≤15 mmHg). The protocol procedures were followed precisely. Results: QardioArm® and Omron M6 Comfort® fulfilled the requirements of the ESH-IP and passed the validation process successfully. For QardioArm®, a total of 69 out of 99 comparisons for systolic blood pressure (SBP) showed an absolute difference within 5 mmHg and 82 out of 99 for diastolic blood pressure (DBP). As for Omron M6 Comfort®, a total of 83 out of 99 comparisons for SBP showed an absolute difference within 5 mmHg and 77 out of 99 for DBP. The mean differences between the device and mercury readings were 0.7±5.9 mmHg for SBP and 0.3±4.1 mmHg for DBP for QardioArm® and −1.4±4.7 mmHg for SBP and −2.1±4.3 mmHg for DBP for Omron M6 Comfort®. With regard to part 2 of ESH-IP 2010, 27 out of 33 subjects had a minimum of two out of three measurements within 5 mmHg difference for SBP and 31 out of 33 subjects for DBP for the QardioArm®, and 29 out of 33 patients had a minimum of two out of three measurements within 5 mmHg difference for SBP and 26 out of 33 patients for DBP for Omron M6 Comfort®.Conclusion: QardioArm® and Omron M6 Comfort® readings differing from the mercury standard by <5, 10, and 15 mmHg fulfill the ESH-IP Revision 2010 requirements. Consequently, these two devices are suitable for use in the general population and non-insulin-dependent type II diabetic patients, respectively. Keywords: QardioArm®, Omron M6 Comfort®, validation, blood pressure measurement, type II diabetes, International Protocol
format article
author Chahine MN
Topouchian J
Zelveian P
Hakobyan Z
Melkonyan A
Azaki A
Diab R
Harb A
Asmar R
author_facet Chahine MN
Topouchian J
Zelveian P
Hakobyan Z
Melkonyan A
Azaki A
Diab R
Harb A
Asmar R
author_sort Chahine MN
title Validation of BP devices QardioArm® in the general population and Omron M6 Comfort® in type II diabetic patients according to the European Society of Hypertension International Protocol (ESH-IP)
title_short Validation of BP devices QardioArm® in the general population and Omron M6 Comfort® in type II diabetic patients according to the European Society of Hypertension International Protocol (ESH-IP)
title_full Validation of BP devices QardioArm® in the general population and Omron M6 Comfort® in type II diabetic patients according to the European Society of Hypertension International Protocol (ESH-IP)
title_fullStr Validation of BP devices QardioArm® in the general population and Omron M6 Comfort® in type II diabetic patients according to the European Society of Hypertension International Protocol (ESH-IP)
title_full_unstemmed Validation of BP devices QardioArm® in the general population and Omron M6 Comfort® in type II diabetic patients according to the European Society of Hypertension International Protocol (ESH-IP)
title_sort validation of bp devices qardioarm® in the general population and omron m6 comfort® in type ii diabetic patients according to the european society of hypertension international protocol (esh-ip)
publisher Dove Medical Press
publishDate 2017
url https://doaj.org/article/6ecb4a3fe0de4dc98ffd54f7539d48b1
work_keys_str_mv AT chahinemn validationofbpdevicesqardioarmreginthegeneralpopulationandomronm6comfortregintypeiidiabeticpatientsaccordingtotheeuropeansocietyofhypertensioninternationalprotocoleship
AT topouchianj validationofbpdevicesqardioarmreginthegeneralpopulationandomronm6comfortregintypeiidiabeticpatientsaccordingtotheeuropeansocietyofhypertensioninternationalprotocoleship
AT zelveianp validationofbpdevicesqardioarmreginthegeneralpopulationandomronm6comfortregintypeiidiabeticpatientsaccordingtotheeuropeansocietyofhypertensioninternationalprotocoleship
AT hakobyanz validationofbpdevicesqardioarmreginthegeneralpopulationandomronm6comfortregintypeiidiabeticpatientsaccordingtotheeuropeansocietyofhypertensioninternationalprotocoleship
AT melkonyana validationofbpdevicesqardioarmreginthegeneralpopulationandomronm6comfortregintypeiidiabeticpatientsaccordingtotheeuropeansocietyofhypertensioninternationalprotocoleship
AT azakia validationofbpdevicesqardioarmreginthegeneralpopulationandomronm6comfortregintypeiidiabeticpatientsaccordingtotheeuropeansocietyofhypertensioninternationalprotocoleship
AT diabr validationofbpdevicesqardioarmreginthegeneralpopulationandomronm6comfortregintypeiidiabeticpatientsaccordingtotheeuropeansocietyofhypertensioninternationalprotocoleship
AT harba validationofbpdevicesqardioarmreginthegeneralpopulationandomronm6comfortregintypeiidiabeticpatientsaccordingtotheeuropeansocietyofhypertensioninternationalprotocoleship
AT asmarr validationofbpdevicesqardioarmreginthegeneralpopulationandomronm6comfortregintypeiidiabeticpatientsaccordingtotheeuropeansocietyofhypertensioninternationalprotocoleship
_version_ 1718401125226381312

Ejemplares similares